Skip to main content
Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma.
Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?
Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation.
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.
Novel influenza A (H1N1) viral infection in pediatric patients with sickle-cell disease.
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.